Mensa Guide - Google Play
You'll be able to see results in few seconds.
Publisher Description
Mensa Guide -Mensa Guide to Antimicrobial Therapy
Mensa Guide is a comprehensive antimicrobial guide, providing up-to-date information for the best therapeutic decision in infectious diseases. The content is organized to provide quick access to the essential information, while allowing to easily delve deeper by opening inline notes.
• Tap on any word in the text to navigate to another entry, to check abbreviations, to view notes, to open calculators or to refer to a bibliographic citation.
• Search from the main screen to find entries according to relevant criteria, or use the full-text search for more specific cases.
• Filter among more than 800 microorganisms according to their characteristics.
• Calculate serum antibiotic concentration, estimated glomerular filtration rate and more than 50 other relevant parameters or scores.
• Access the most recent and complete information available. Content is constantly under review according to the evolution of resistance rates, the appearance of new pathogens and antimicrobials, epidemiological changes and the publication of reviews or treatment consensus in the most prestigious journals.
Note: use of the Mensa Guide requires an annual subscription of $19.99 or a monthly subscription of $1.99 (price may vary by region), with a 30-day free trial period. A subscription allows the use of the Mensa Guide on all your Android devices
--
About auto-renewing subscriptions:
– An in-app subscription is one month for $1.99 or one year for $19.99.
– Payment will be charged to your Play Store account at confirmation of purchase.
– Subscriptions automatically renew unless auto-renew is turned off at least 24-hours before the end of the current period.
– Your account will be charged for renewal within 24-hours prior to the end of the current period for $1.99 or $19.99.
– Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase.
– Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication, where applicable.
Terms & Conditions: http://www.garmenmed.com/terms.html
--
Disclaimer:
This app is not intended for the general public but for health care professionals. Although we make every effort to ensure that the data is accurate, we are not responsible for any errors or omissions that the app may contain. The application of the information provided in a particular situation remains the sole responsibility of the health care professional.
--
We would love to hear your suggestions, recommendations or corrections. Contact us at mensaguide@garmenmed.com
About Mensa Guide
The company that develops Mensa Guide is GARMENMED SCP. The latest version released by its developer is 1.0.
To install Mensa Guide on your Android device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2026-11-14 and was downloaded 0 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the Mensa Guide as malware if the download link to es.app.guia.mensa is broken.
How to install Mensa Guide on your Android device:
- Click on the Continue To App button on our website. This will redirect you to Google Play.
- Once the Mensa Guide is shown in the Google Play listing of your Android device, you can start its download and installation. Tap on the Install button located below the search bar and to the right of the app icon.
- A pop-up window with the permissions required by Mensa Guide will be shown. Click on Accept to continue the process.
- Mensa Guide will be downloaded onto your device, displaying a progress. Once the download completes, the installation will start and you'll get a notification after the installation is finished.
Program Details
System requirements
Download information
Pricing
Version History
version
posted on 2026-11-14
• Changes in bedaquiline, cefazolin, cefepime, favipiravir, fosmanogepix, linezolid, quinolones. Actinomadura, Curtobacterium, M. leprae, M. tuberculosis, M. pneumoniae, Nocardia, Proteus, S. aureus, S. agalactiae, S. suis, Streptomyces, viridans group streptococcus; Aspergillus, Candida, Paracoccidioides; HBV, LCMV, MARV, Orthohantavirus; Mesocestoides. Acute meningitis. Mycetoma. Other entries.• Minor updates to the vancomycin dose adjustment calculator.
version
posted on 2026-11-06
Changes in bictegravir, cefiderocol, dolutegravir, emtricitabine, lamivudine, omadacycline, tenofovir, velpatasvir, ECOFF values (eravacycline). Kosakonia, M. chelonae, M. genitalium, Proteus, P. aeruginosa, S. aureus; Candida; HEV, HIV, R. ratti, SARS-CoV-2, USUV, WNV; Schistosoma. β-lactam-resistant Enterobacterales infections. Cystitis. Flavivirus encephalitis. Hidradenitis suppurativa. Infectious arthritis. Osteomyelitis. Prophylaxis of invasive fungal disease in onco-hematologic patients.
version
posted on 2026-10-16
Changes in linezolid, miltefosine, olorofim, tecovirimat, tedizolid, ECOFF values. B. cepacia, B. pseudomallei, M. tuberculosis, Ralstonia, S. aureus; Aspergillus, Basidiobolus, Candida, Coccidioides, Conidiobolus; Orthobunyavirus; YGTV; Blastocystis, D. fragilis, free-living amoebae, P. falciparum. Encephalitis. Infections of the eyelid, lacrimal system, conjunctiva, or cornea. Infective endocarditis. Intra-abdominal abscesses. Sepsis and septic shock. Sinusitis. Other entries.
version
posted on 2026-10-09
• Added Candida score to Utilities.
• Changes in dalbavancin, meropenem, monoclonal antibodies, rifabutin, tebipenem, velpatasvir. Actinotignum, C. burnetii, Helicobacter, M. avium, M. tuberculosis, M. ulcerans, viridans group streptococci; Candida; CCHFV, CHIKV, EBOV, HAV, HCV, HIV, influenza, measles, SFTSV, Thogotovirus; Onchocerca. Chorioamnionitis. Guillain-Barré syndrome. IV catheter infection. Odontogenic infections. Otitis media. Pharyngotonsillitis. Pneumonia. Other entries.
version
posted on 2026-09-25
Changes in amphotericin B deoxycholate, caspofungin, ceftobiprole, fosfomycin, linezolid, omadacycline, pritelivir, rifabutin. Acinetobacter, Borrelia burgdorferi, Clostridioides difficile, CoNS, Enterococcus, Helicobacter, Leptospira; Aspergillus, Candida, Coccidioides, Histoplasma, Lomentospora, Pneumocystis jirovecii, Pythium; HSV-1 and HSV-2, SARS-CoV-2. Encephalitis. Fever without an apparent source in travelers returning from the tropics. Glucocorticoids in ID. Other entries.
version
posted on 2026-09-18
Changes in cloxacillin, isoniazid, islatravir, marivabir, voriconazole. L. clevelandensis, Megasphaera, N. gonorrhoeae, N. meningitidis, Pandoraea, Providencia, P. aeruginosa, S. aureus, viridans group Streptococcus; Candida; OROV, PyV, RSV; Thelazia, T. gondii. Encephalitis. Glucocorticoids in infectious diseases. Infectious arthritis. Infective endocarditis. Sepsis and septic shock. Skin, subcutaneous tissue, and fascia infections. Other entries.
version
posted on 2026-09-12
Changes in cefazolin, cefiderocol, ceftazidime, remdesivir, vancomycin. Clostridioides difficile, Elizabethkingia, Haemophilus influenzae, Pseudomonas aeruginosa, Salmonella, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus other spp, Treponema pallidum, Weeksella; MPXV, SARS-CoV-2; Plasmodium falciparum. Biomarkers of inflammation/infection. Infectious arthritis. Mastitis and breast abscess. Prevention against H. influenzae. VZV vaccine.
version
posted on 2026-08-28
• Added pritelivir to Antimicrobials.
• Changes in ciprofloxacin, dalbavancin, gepotidacin, letermovir, oseltamivir. Clostridioides difficile, Mycobacterium tuberculosis, Mycoplasma genitalium, Mycoplasma pneumoniae, Staphylococcus lugdunensis; Aspergillus, Fonsecaea, Rhizopus, Scedosporium; HHV-6, HSV, influenza, VZV; Leishmania. β-lactam-resistant Enterobacterales infections. Infective endocarditis. Pneumonia. Aspergillosis (chemoprophylaxis).
version
posted on 2026-08-15
Changes in amoxicillin, cefiderocol, dalbavancin, gepotidacin, isavuconazole, linezolid, quinolones, sulopenem, terbinafine, vancomycin, voriconazole. Acinetobacter, E. coli, Helicobacter, Klebsiella, Leptospira, M. tuberculosis, M. pneumoniae, N. gonorrhoeae, P. aeruginosa, Stenotrophomonas; Talaromyces. Anaerobic infection. β-lactam-resistant Enterobacterales infections. Hemolytic uremic syndrome. Pneumonia. Staphylococcus aureus (chemoprophylaxis in asymptomatic carriers).
version
posted on 2026-08-08
• Added islatravir to Antimicrobials.
• Changes in oritavancin, piperacillin/tazobactam, posaconazole, tebipenem, voriconazole. Acinetobacter, C. difficile, C. tetani, N. gonorrhoeae, Stenotrophomonas, Trueperella; Candida, Mucor; T. cruzi. β-lactam-resistant Enterobacterales infections. Chorioamnionitis. Cystitis. Exacerbations of COPD. Healthcare-associated meningitis and ventriculitis. Infections in patients with major burns. Infectious diarrhea. Infective endocarditis. Pyelonephritis.
Disclaimer
Official Google Play Link
We do not host Mensa Guide on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Google and passed their terms and conditions to be listed there. We recommend caution when installing it.
The Google Play link for Mensa Guide is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.



